Interestingly, Mitton et al. (12) provided evidence that a CBP–CREB interaction blocker disrupts CREB-driven gene expression, causing cell cycle arrest and apoptosis of AML cells. The gene discussed is CREB1; the disease is acute myeloid leukemia.